Crinetics Pharmaceuticals, Inc.
← Back to CRNX Overview

Crinetics Pharmaceuticals, Inc. (CRNX)

Profitability & Net Margin History

Current Net Margin

-3161.26%

Crinetics Pharmaceuticals, Inc. currently has a net profit margin of -3161.26%.

Financial Fundamentals

CRNXQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.00-0.12-3161.26%8781147
2025-09-300.00-0.13-90972.73%7975672
2025-06-300.00-0.12-11216.00%1559120
2025-03-310.00-0.10-26807.20%
2024-12-310.00-0.08
2024-09-300.00-0.08
2024-06-300.00-0.07-18560.15%810234
2024-03-310.00-0.07-10457.81%
2023-12-310.00-0.06
2023-09-300.00-0.06-16606.36%1144654
2023-06-300.00-0.05-5159.82%344295
2023-03-310.00-0.05-1716.87%462883
2022-12-310.00-0.04-6345.70%280823
2022-09-300.00-0.04-9153.93%49869
2022-06-300.00-0.04-9652.62%854668
2022-03-310.00-0.03-1105.94%175065
2021-12-310.00-0.03-2856.59%
2021-09-300.00-0.03
2021-06-300.00-0.03
2021-03-310.00-0.02
2020-12-310.00-0.02
2020-09-300.00-0.02
2020-06-300.00-0.02
2020-03-310.00-0.02
2019-12-310.00-0.01
2019-09-300.00-0.01
2019-06-300.00-0.01
2019-03-310.00-0.01
2018-12-310.00-0.01
2018-09-300.00-0.01
2018-06-300.00-0.01
2018-03-310.00-0.01
2017-12-310.00-0.00
2017-09-300.00-0.00
2017-06-300.00-0.00
2017-03-310.00-0.00

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.